During the presidential election, healthcare will be top of mind especially for patients with access issues or significant health issues, Eleanor Perfetto, PhD, senior vice president of strategic initiatives for the National Health Council. As long as patients feel the healthcare system is engaging them and listening to them, they don't care what it is called.
Healthcare providers need to agree on a definition of value, but that discussion must include the voice of the patient, according to Eleanor Perfetto, PhD, senior vice president of strategic initiatives for the National Health Council. Patient input is especially important when the conversation results in a decision that could affect access to care.
Finding the right balance between value and cost of health care requires input from all elements of the health community – especially from patients. The National Pharmaceutical Council (NPC) brought together stakeholders for a conference on Assessing Value: Promise & Pitfalls. This webcast video features the opening statement by NHC Senior Vice President of Strategic Initiatives Eleanor Perfetto.
The National Pharmaceutical Council (NPC) brought together stakeholders for a conference on Assessing Value: Promise & Pitfalls. This webcast video features the closing statements by Perfetto and the panelists addressing how to Move Value Frameworks from Fledgling to Functional.
At the National Academy of Medicine's public symposium, NHC CEO Marc Boutin was asked what he would say to the next President of the United States if he was given 5 minutes to recommend ways to improve the health care system.
The National Academy of Medicine held a public symposium on September 26. In this video, NHC Chief Executive Officer Marc Boutin discusses the recommendations submitted by the NHC and other thought-leaders and how to create a high-quality health care system.
The Food and Drug Administration held a public meeting on August 15, 2016, to take public statements on the reauthorization of the Prescription Drug User Fee Act (PDUFA). National Health Council Chief Executive Officer Marc Boutin presented on behalf of the nation's leading patient advocacy organizations. His video was from the FDA webcast of the hearing
Marc Boutin, CEO, interviewed by Paul Simms, Chairman of eyeforpharma, regarding engaging patients in drug development.
An interview with Peter Segall, General Manager, Edelman.
An interview with David Meeker, Executive Vice President, Head Sanofi-Genzyme.
Dr. Francis Collins, Director, National Institutes of Health, reviewed the top five trends shaping the health care landscape and the importance of the NIH and patient organizations working together.
An interview with Eric Letsinger, Founder, Quantified Ventures on emerging issues in the health community and ways to strengthen patient advocacy organizations.
An interview with Jason Saul, Founder and CEO, Mission Measurement and Adjunct Lecturer, Kellogg School of Management, Northwestern University.
NHC Senior Vice President of Strategic Initiatives, Eleanor Perfetto, discusses her research at the University of Maryland on how patients with rare diseases can become empowered through involvement in patient-centered research.
NHC CEO Marc Boutin discusses the importance of patient-centeredness in the health care system during a forum hosted by The Hill.
NHC CEO Marc Boutin participates in a roundtable discussion on value-based medicine and designing a patient-centered health care system during a forum hosted by The Hill.
NHC CEO Marc Boutin was one of the presenters on a panel of patient advocates speaking to the Board of Directors of the Patient-Centered Outcomes Research Institute. He discussed the role the NHC played in creating PCORI and hte patient community's ongoing support for the Institute's work to advance patient-centered outcomes research.
NHC CEO Marc Boutin was a panelist during a FDA public meeting in July 2015. The panel outlined the FDA's goals in the reauthorization process.
U.S. Secretary of Health and Human Services, Sylvia Burwell, brought together stakeholders from throughout the health community on November 20, 2015, to discuss how to address the complex problem of balancing access to medications and encouraging innovation. NHC CEO Marc Boutin participated in a panel discussing the issues from the patient and consumer perspectives.
NHC CEO Marc Boutin, in an interview with Patient Focused Medicines Development, states, "We need treatments that reflect values that are important to patients."